Presenter(s): Grace Katie Bell, MSN, RN-BC, CARN, PHN, Crystal Walker, DMSc, PA-C, and Faith Butler, MD

Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior

Cost: No fee

Target Audience: Physicians, nurse practitioners or other advanced practice nurses, PAs, psychologists, clinical administrators and healthcare teams.

Credit Designations Available: AMA PRA Category 1 Credit™, Nursing Contact Hours, AAPA Category 1 CME credit,  and Interprofessional Continuing Education (IPCE) credit.

Webinar Description: After the organizational and clinical components of initiating OUD treatment have been mapped out, how do we begin effective implementation? This session will map out concrete clinical and patient flow activities and consider issues of documentation, charting, and recommended metrics. We will review steps for conducting a small pilot/demonstration buprenorphine project, with regular outcomes-monitoring to ensure a smooth scale up of treatment and care for patients with OUD. This includes doing a walk-through to ensure behavioral health and prescriber staff have the certifications, knowledge and skills to deliver buprenorphine, or other pharmacotherapies, in integrated settings. We will discuss approaches for utilizing leadership and staff check-ins to get a pulse on practices, scale up, and changes needed to ensure successful expansion across all administrative and clinical staff. Finally, we will consider which metrics –immediate and long-term– are meaningful to your site, and how to gather relevant data to support federal/state reporting requirements, process improvement goals, and clinical decision-making in MOUD delivery.

Educational Objectives:

• Demonstrate skills to map out a site-specific patient flow and staff flow, including roles and tasks of team members
• Determine which metrics – immediate and long-term – are valuable to their program and how to gather relevant data
• Consider how information from their EHR can be used to support reporting requirements, process improvement goals, and clinical decision-making in MOUD delivery
• Describe how to set up protocols ensuring patient confidentiality (42 CFR, pt. 2)